Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
- 13 March 2012
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (9), 2908-2916
- https://doi.org/10.1245/s10434-012-2301-y
Abstract
Epidemiologic studies have reported a positive correlation between body mass index (BMI) and pancreatic cancer risk, but clinical relevance of obesity and/or body fat distribution on tumor characteristics and cancer-related outcome remain controversial. We sought to assess the influence of obesity and body fat distribution on pathologic characteristics and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Demographic and biometric data were collected on 328 patients undergoing pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. In a subset of patients, pancreatic fatty infiltration and fibrosis were assessed pathologically, and visceral fat area (VFA) was evaluated. Influence of BMI and body fat distribution on tumor characteristics and survival were evaluated. A significant positive correlation between BMI and VFA was observed, with a wide range of VFA value within each BMI class. According to BMI or VFA distribution, there were no significant differences in patient characteristics, intraoperative or perioperative outcome, or pathologic characteristics, with the exception of significantly higher blood loss in patients with an increased body weight or VFA. Unadjusted overall and disease-free survival between BMI class and VFA quartile were not significantly different. In this study, obesity and body fat distribution were not correlated with specific tumor characteristics or cancer-related outcome.Keywords
This publication has 39 references indexed in Scilit:
- Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinomaHPB, 2011
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer riskInternational Journal of Cancer, 2010
- Obesity adversely affects survival in pancreatic cancer patientsCancer, 2010
- Anthropometric Measures, Body Mass Index, and Pancreatic CancerArchives of Internal Medicine, 2010
- Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerGut, 2009
- The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic CancerJournal of Gastrointestinal Surgery, 2009
- Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic CancerJAMA, 2009
- Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotionProceedings of the National Academy of Sciences, 2009
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004